|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
FY2020
12 months to Sep 30, 2020
|
FY2019
12 months to Sep 30, 2019
|
FY2018
12 months to Sep 30, 2018
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net Income (Loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation expense | |||||
| Provision for Loan Losses | |||||
| Deferred income taxes expense | |||||
| ESOP expense | |||||
| Stock based compensation | |||||
| Amortization of premiums and discounts on investment securities, net | |||||
| Amortization of loan origination fees and costs | |||||
| Amortization of mortgage service rights | |||||
| Amortization of subordinated debt issuance costs | |||||
| Net gain on sale and call of investment securities available for sale | |||||
| Net loss on sale of fixed assets | |||||
| Net gain on disposal of fixed assets | |||||
| Net gain on sale of secondary market loans | |||||
| Proceeds on sale of secondary market loans | |||||
| Originations of secondary market loans | |||||
| Valuation write down of other real estate owned | |||||
| Earnings on bank-owned life insurance | |||||
| (Increase) decrease in accrued interest receivable | |||||
| Decrease in accrued interest payable | |||||
| Operating lease liability payments | |||||
| Amortization of right of use asset | |||||
| Change in fair value of equity securities | |||||
| Decrease in other liabilities | |||||
| Decrease in other assets | |||||
| Net Cash Provided by Operating Activities | |||||
| Investment securities available-for-sale: | |||||
| Purchases, available for sale | |||||
| Sales, available for sale | |||||
| Maturities, calls and principal repayments, available for sale | |||||
| Investment securities held-to-maturity: | |||||
| Maturities, calls and principal repayments | |||||
| Net increase in loans | |||||
| Purchases, held to maturity | |||||
| Maturities, calls and principal repayments, held to maturity | |||||
| Proceeds from sale of loans held for sale | |||||
| Net decrease in loans | |||||
| Purchase of bank-owned life insurance | |||||
| Proceeds from death benefit on bank-owned life insurance | |||||
| Net decrease in restricted stock | |||||
| Proceeds from sales and disposals of property and equipment | |||||
| Purchases of property and equipment | |||||
| Net Cash Provided by Investing Activities | |||||
| Cash Flows from Financing Activities | |||||
| Net (decrease) increase in deposits | |||||
| Proceeds for short-term borrowings | |||||
| Proceeds for long-term borrowings | |||||
| Repayment of long-term borrowings | |||||
| Repayment of other borrowed money | |||||
| (Decrease) in advances from borrowers for taxes and insurance | |||||
| Net proceeds from issuance of common stock | |||||
| Acquisition of treasury stock | |||||
| Net Cash (Used in) Provided by Financing Activities | |||||
| Cash and Cash Equivalent - Beginning | |||||
| Cash and Cash Equivalent - Ending | |||||
| Net (Decrease) Increase in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalent – Beginning | |||||
| Cash and Cash Equivalent – Ending | |||||
| Supplementary Cash Flows Information | |||||
| Interest paid | |||||
| Non-cash transfer of loans to OREO | |||||
| Income taxes paid | |||||
| Right-of-use asset | |||||
| Operating lease liability | |||||
| Non-cash proceeds from sale of OREO | |||||
Loading...